158
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assessment of the Risk and Symptoms of SARS-CoV-2 Infection Among Healthcare Workers During the Omicron Transmission Period: A Multicentric Study from Four Hospitals of Mainland China

, , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 3315-3328 | Received 22 Mar 2023, Accepted 17 May 2023, Published online: 29 May 2023

References

  • World Health Organization. WHO coronavirus (COVID-19) dashboard; 2023. Available from: https://covid19.who.int/. Accessed May 19, 2023.
  • O’Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140–145. doi:10.1038/s41586-020-2918-0
  • China National Bureau of Statistics. Interpretation for the 7th census of China; 2021. Available from: http://www.stats.gov.cn/xxgk/jd/sjjd2020/202105/t20210512_1817342.html. Accessed May 19, 2023.
  • Cao Y, Wang J, Jian F, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657–663. doi:10.1038/s41586-021-04385-3
  • Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303–1312. doi:10.1016/S0140-6736(22)00462-7
  • Su S, Du L, Jiang S. Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol. 2021;19(3):211–219. doi:10.1038/s41579-020-00462-y
  • Zeng G, Wu Q, Pan H, et al. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled Phase 2 clinical trials. Lancet Infect Dis. 2022;22(4):483–495. doi:10.1016/S1473-3099(21)00681-2
  • Huang Z, Xu S, Liu J, et al. Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study. Nat Commun. 2023;14(1). doi:10.1038/s41467-023-37673-9
  • Cegolon L, Negro C, Mastrangelo G, Filon FL; and group O.w. Primary SARS-CoV-2 infections, re-infections and vaccine effectiveness during the omicron transmission period in healthcare workers of Trieste and Gorizia (Northeast Italy). Viruses. 2021;14(12). doi:10.3390/v14122688
  • Cegolon L, Ronchese F, Ricci F, Negro C, Larese-Filon F. SARS-CoV-2 infection in health care workers of Trieste (North-Eastern Italy), 2022: occupational risk and the impact of the Omicron Variant. Viruses. 2022;14(8):1663. doi:10.3390/v14081663
  • National health commission of the People’s Republic of China, policies on COVID-19 prevention and control. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/list_gzbd.shtml. Accessed May 19, 2023.
  • Tegally H, Moir M, Everatt J, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022;28(9):1785–1790. doi:10.1038/s41591-022-01911-2
  • Wang Q, Iketani S, Li Z, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2023;186(2):279–286 e278. doi:10.1016/j.cell.2022.12.018
  • Viana R, Moyo S, Amoako DG, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in Southern Africa. Nature. 2022;603(7902):679–686. doi:10.1038/s41586-022-04411-y
  • Basso P, Negro C, Cegolon L, Larese Filon F. Risk of vaccine breakthrough SARS-CoV-2 infection and associated factors in healthcare workers of Trieste teaching hospitals (North-Eastern Italy). Viruses. 2022;14(2). doi:10.3390/v14020336
  • Tsui WNT, Hamill V, Noll L, et al. Molecular detection of SARS-CoV-2 and differentiation of Omicron and Delta variant strains. Transbound Emerg Dis. 2022;69(5):e1618–e1631. doi:10.1111/tbed.14497
  • Firew T, Sano ED, Lee JW, et al. Protecting the front line: a cross-sectional survey analysis of the occupational factors contributing to healthcare workers’ infection and psychological distress during the COVID-19 pandemic in the USA. BMJ Open. 2020;10(10):e042752. doi:10.1136/bmjopen-2020-042752
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
  • Hui KPY, J.c.w. H, Cheung MC, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603(7902):715–720. doi:10.1038/s41586-022-04479-6
  • Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618–1624. doi:10.1016/S0140-6736(22)00327-0
  • Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease. Physiol Rev. 2019;99(3):1325–1380. doi:10.1152/physrev.00010.2018
  • Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev. 2012;16(2):137–149. doi:10.1016/j.smrv.2011.05.001
  • Ragnoli B, Pochetti P, Pignatti P, et al. Sleep deprivation, immune suppression and SARS-CoV-2 infection. Int J Environ Res Public Health. 2022;19(2):904. doi:10.3390/ijerph19020904
  • Mello MT, Silva A, Guerreiro RC, et al. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment. Sleep Sci. 2020;13(3):199–209. doi:10.5935/1984-0063.20200062
  • Kim H, Hegde S, LaFiura C, et al. COVID-19 illness in relation to sleep and burnout. BMJ Nutr Prev Health. 2021;4(1):132–139. doi:10.1136/bmjnph-2021-000228
  • Parry DA, Oeppen RS, Amin MSA, Brennan PA. Sleep: its importance and the effects of deprivation on surgeons and other healthcare professionals. Br J Oral Maxillofac Surg. 2018;56(8):663–666. doi:10.1016/j.bjoms.2018.08.001
  • Ferini-Strambi L, Zucconi M, Casoni F, Salsone M. COVID-19 and sleep in medical staff: reflections, clinical evidences, and perspectives. Curr Treat Options Neurol. 2020;22(10):29. doi:10.1007/s11940-020-00642-4
  • Passioti M, Maggina P, Megremis S, Papadopoulos NG. The common cold: potential for future prevention or cure. Curr Allergy Asthma Rep. 2014;14(2):413. doi:10.1007/s11882-013-0413-5
  • Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15(6):335–349. doi:10.1038/nri3843
  • Planas D, Saunders N, Maes P, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602(7898):671–675. doi:10.1038/s41586-021-04389-z